1. Home
  2. Analysis
  3. Decadron
  4. Minipress

Decadron and Minipress drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Decadron and Minipress. Common interactions include diarrhoea among females and bronchiolitis among males.

The phase IV clinical study analyzes what interactions people who take Decadron and Minipress have. It is created by eHealthMe based on reports of 9 people who take Decadron and Minipress from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 29, 2022

9 people who take Decadron and Minipress together, and have interactions are studied.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 45,092 Decadron users for its effectiveness, alternative drugs and more.

What is Minipress?

Minipress has active ingredients of prazosin hydrochloride. It is often used in post-traumatic stress disorder. eHealthMe is studying from 2,098 Minipress users for its effectiveness, alternative drugs and more.

Number of Decadron and Minipress reports submitted per year:

Decadron and Minipress drug interactions.

Common Decadron and Minipress drug interactions by gender *:

female:

  1. Diarrhoea
  2. Chest pain
  3. Constipation
  4. Dyspnoea
  5. Pulmonary embolism
  6. Renal failure
  7. Thrombosis
  8. Gastric disorder
  9. Vomiting

male:

  1. Bronchiolitis
  2. Cerebral infarction
  3. Respiratory failure
  4. Diabetes mellitus
  5. Disseminated intravascular coagulation
  6. Hyperkalaemia
  7. Pneumonia
  8. Autonomic failure syndrome
  9. General physical health deterioration
  10. Hemiparesis

Common Decadron and Minipress drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Bronchiolitis
  2. Diabetes mellitus
  3. Hyperkalaemia
  4. Pneumonia

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cerebral infarction
  2. Chest pain
  3. General physical health deterioration
  4. Hemiparesis
  5. Pancreatic carcinoma
  6. Respiratory failure
  7. Constipation
  8. Diarrhoea
  9. Disseminated intravascular coagulation
  10. Dyspnoea

* Approximation only. Some reports may have incomplete information.

Do you take Decadron and Minipress?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Decadron and Minipress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Decadron side effects:

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Minipress side effects:

Browse all side effects of Minipress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Decadron interactions:

Browse all interactions between Decadron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Minipress interactions:

Browse all interactions between Minipress and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone and prazosin hydrochloride (the active ingredients of Decadron and Minipress, respectively), and Decadron and Minipress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Decadron and Minipress.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.